Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Grant US-11723963-B2 United States of America 15 Aug 2023
Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist… Grant US-11338027-B2 United States of America 24 May 2022
Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions Grant US-10874730-B2 United States of America 29 Dec 2020
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Grant US-10434155-B2 United States of America 08 Oct 2019
INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES Application EP-3511013-A1 European Patent Office 17 Jul 2019
GP100-specific T cell receptors and related materials and methods of use Grant US-9522948-B2 United States of America 20 Dec 2016
A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST… Application WO-2016146259-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2016
Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof Grant US-9283276-B2 United States of America 15 Mar 2016
Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease Grant US-9090693-B2 United States of America 28 Jul 2015
EPHA3 AND MULTI-VALENT TARGETING OF TUMORS Application WO-2015070210-A1 World Intellectual Property Organisation (WIPO) 14 May 2015
Treatment method using EGFR antibodies and SRC inhibitors and related formulations Grant US-9023356-B2 United States of America 05 May 2015
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Grant US-8859488-B2 United States of America 14 Oct 2014
Methods for up-regulating antigen expression in tumors Grant US-8071321-B2 United States of America 06 Dec 2011